Fusion Antibodies plc

Default features description for sign up page.

Updates

Regulatory News

Company Presentations

Webinars

Board Profiles

Company Profile

Home

Fusion Deep Dive

Advisers

Company Information & FAQs

Corporate Governance

Share Price

New investors

Shareholder Information

Raleway

In this episode, Chief Scientific Officer Richard Buick unpacks the science and significance of Fusion’s Opti Library, a cornerstone of their antibody discovery toolkit.

Richard explains what makes the Opti Library unique: a highly diverse, carefully curated collection of antibody sequences designed to accelerate the identification of promising therapeutic candidates. He highlights how the library’s design maximises both breadth and quality, giving researchers access to antibodies with the structural and functional characteristics needed for success.

By combining scientific depth with practical application, the Opti Library strengthens Fusion’s ability to deliver discovery programs faster, with greater precision, and with a higher chance of producing antibodies that translate into real-world therapies.

Watch now and submit your questions below.

Deep Dive: The Opti Library